Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

3:55 PM - 4:00 PM PT

Closing
Speaker: Lam, Miranda, MD, MBA - Brigham and Women's / Dana-Farber Cancer Institute, Boston, MA
5:00 PM - 5:10 PM PT

258 - Acute Toxicity in SWOG 1706, a Randomized Trial Comparing Radiotherapy for Inflammatory Breast Cancer with and without Concurrent Olaparib
Speaker: Jagsi, Reshma, MD, PhD, FASTRO - Emory University School of Medicine, Atlanta, GA
5:00 PM - 5:10 PM PT

263 - Stereotactic Radiation for Systemic Therapy-Naïve Oligometastatic Kidney Cancer: Final Results of a Phase IIb Trial
Speaker: Assadi, Ryan, DO, MS - UTSW, Dallas, TX
5:00 PM - 5:10 PM PT

268 - Ten-Year Outcomes of the Revised STARS Trial Comparing Radiation and Surgery for Early-Stage Non-Small Cell Lung Cancer
Speaker: Kleber, Troy, MD, MS - MD Anderson Cancer Center, Houston, TX
5:00 PM - 5:10 PM PT

273 - First Characterization of a State-of-the-Art Upright CT Scanner for High Precision Proton Therapy
Speaker: Glide-Hurst, Carri, PhD - University of Wisconsin Madison, Madison, WI
5:00 PM - 6:00 PM PT

GU 6: Revelations in Renal Radiotherapy
Speaker: Nagar, Himanshu, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
5:00 PM - 6:00 PM PT

GU 6: Revelations in Renal Radiotherapy
Speaker: Olson, Adam, MD, MS - UPMC Hillman Cancer Center, Pittsburgh, PA
5:00 PM - 5:05 PM PT

Introduction
Speaker: Dyer, Brandon, MD - Legacy Health System-Good Samaritan Hospital, Portland , OR
5:00 PM - 5:05 PM PT

Introduction
Speaker: Jhingran, Anuja, MD, BS, FASTRO - MD Anderson Cancer Center, Houston, TX
5:00 PM - 6:00 PM PT

Lung 3: NSCLC Early Stage and SBRT
Speaker: Cheng, Simon, MD, PhD - Columbia University Irving Medical Center, New York, New York
5:00 PM - 6:00 PM PT

Lung 3: NSCLC Early Stage and SBRT
Speaker: Ye, Jason, MD - University of Southern California USC Norris Cancer Hospital, Los Angeles, CA
5:05 PM - 5:10 PM PT

1024 - Phase I Study of Hypofractionated Whole Pelvis Radiation in Endometrial Cancer Using a Novel Patient-Reported Outcomes Continual Reassessment Method (PRO-CRM)
Speaker: Feldkamp, Sarah, MD - University of Cincinnati, Cincinnati, OH